首页> 美国卫生研究院文献>Schizophrenia Research and Treatment >Effectiveness of Integrated Neurocognitive Therapy on Cognitive Impairment and Functional Outcome for Schizophrenia Outpatients
【2h】

Effectiveness of Integrated Neurocognitive Therapy on Cognitive Impairment and Functional Outcome for Schizophrenia Outpatients

机译:综合神经认知疗法对精神分裂症门诊病人认知障碍和功能结局的有效性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cognitive impairment is highly prevalent in patients with schizophrenia and schizoaffective disorder. Many interventions have been developed to treat cognitive deficit, since it has a strong impact on functional outcome; however, there are no integrated interventions targeting multiple neuro- and social-cognitive domains with a particular focus on the generalization of the effects of therapy on the functional outcome. Recently, a group of experts has developed a cognitive remediation group therapy approach called Integrated Neurocognitive Therapy (INT), which includes exercises to improve the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) neuro- and social-cognitive domains. This systematic review and meta-analysis aimed to assess the efficacy of this approach. We conducted a search of PubMed, Scopus, Web of Science, and PsycINFO to select primary studies evaluating INT in schizophrenic and schizoaffective patients. The primary outcomes of the meta-analysis included negative and positive symptoms and global functioning. Two randomized controlled trials met inclusion criteria. A total of 217 participants were included. Based on the results from the Positive and Negative Syndrome Scale (PANSS), a significant pooled effect size was observed for negative symptoms, which demonstrated not only an improvement in the patients treated immediately after therapy but also a permanence of positive results at a 9–12-month follow-up. On the other hand, no significant effect size was observed for positive symptoms. In addition, a significant pooled effect size was found for Global Assessment of Functioning (GAF), which shows how INT's integrated approach has lasting positive implications on patients' functional outcome. We concluded that INT might be an effective treatment for negative symptoms and global functioning in patients with schizophrenia, compared to treatment as usual (TAU).
机译:精神分裂症和精神分裂症患者的认知障碍非常普遍。已经开发出许多干预措施来治疗认知功能障碍,因为它对功能预后有很大影响。然而,目前还没有针对多个神经和社会认知领域的综合干预措施,尤其着重于治疗对功能结局的影响的普遍化。最近,一组专家开发了一种称为综合神经认知疗法(INT)的认知矫正小组疗法,其中包括改善MATRICS(改善精神分裂症认知的测量和治疗研究)神经和社会认知领域的练习。这项系统的审查和荟萃分析旨在评估这种方法的有效性。我们对PubMed,Scopus,Web of Science和PsycINFO进行了搜索,以选择评估精神分裂症和精神分裂症患者中INT的主要研究。荟萃分析的主要结果包括阴性和阳性症状以及整体功能。两项随机对照试验符合纳入标准。共有217名参与者。根据阳性和阴性综合征量表(PANSS)的结果,阴性症状观察到显着的合并效应量,这不仅表明治疗后即刻治疗的患者有所改善,而且在9- 12个月的随访。另一方面,对于阳性症状未观察到显着的影响大小。此外,在全球功能评估(GAF)中发现了显着的合并效应量,这表明INT的综合方法如何对患者的功能结局具有持久的积极影响。我们得出的结论是,与通常的治疗(TAU)相比,INT可能是精神分裂症患者阴性症状和整体功能的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号